Pharmalot Archives

Pharmalot Ed Silverman

Solicitor general recommends Supreme Court shouldn’t review an Amgen patent case

Pharmalot Ed Silverman

Inflation caused another big drop in net drug prices, analysis finds

Pharmalot Ed Silverman

Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority

Pharmalot Ed Silverman

Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent

Pharmalot Ed Silverman

Catalent is scolded by FDA for quality control issues at a plant that helps make Covid-19 vaccines

Pharmalot Ed Silverman

Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract

Pharmalot Ed Silverman

Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill

Pharmalot Ed Silverman

Pharmalittle: FDA approves new type of psoriasis drug; U.S. starts late-stage trial to test an antiviral against monkeypox

Pharmalot Ed Silverman

USDA starts cracking down on companies that ship animals without timely inspections

Pharmalot Ed Silverman

J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money

Pharmalot Ed Silverman

What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency

Pharmalot Ed Silverman

Even before Covid-19, remote trials saved money. Will pharma now rely on them more than ever?

Pharmalot Ed Silverman

Pharmalittle: FDA advisers recommend approval of controversial ALS drug; judge rules against coverage of HIV prevention drugs

Pharmalot Ed Silverman

Pharmalittle: FDA holds rare second meeting over an ALS drug; U.S. to expand distribution for monkeypox vaccine

Pharmalot Ed Silverman

Pharma donations to patient charities may violate the ‘spirit’ of anti-kickback laws

Pharmalot Ed Silverman

Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks

Pharmalot Ed Silverman

Pharmalittle: Illumina deal for Grail is blocked after EU veto; CVS buys Signify to expand into house calls

Pharmalot Jason Mast

Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics

Pharmalot Jonathan Wosen

Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics

Pharmalot Jonathan Wosen

Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year

Pharmalot Allison DeAngelis

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

Pharmalot Allison DeAngelis

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

Pharmalot Ed Silverman

Pharmalot

Most Read

Pharmalittle: Haleon argues it’s not liable for any Zantac claims; FDA steps up surprise inspections in India

Pfizer accused of running a fellowship program that discriminates on racial grounds

Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots

Up and down the ladder: The latest comings and goings

Pharmalittle: CRISPR-based drug shows promise in preliminary study; FDA user fee program prompts fresh worries over conflicts

Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug

Pharmalittle: Swiss authorities probe Novartis over patent used to block rivals; Medicare underserves older Americans with opioid use disorder

Swiss authorities raid Novartis offices seeking info on patents used to block rivals

All Coverage

Solicitor general recommends Supreme Court shouldn’t review an Amgen patent case

Inflation caused another big drop in net drug prices, analysis finds

Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority

Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent

Catalent is scolded by FDA for quality control issues at a plant that helps make Covid-19 vaccines

Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract

Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill

Pharmalittle: FDA approves new type of psoriasis drug; U.S. starts late-stage trial to test an antiviral against monkeypox

USDA starts cracking down on companies that ship animals without timely inspections

J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review

Up and down the ladder: The latest comings and goings

Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money

What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency

Even before Covid-19, remote trials saved money. Will pharma now rely on them more than ever?

Pharmalittle: FDA advisers recommend approval of controversial ALS drug; judge rules against coverage of HIV prevention drugs

Pharmalittle: FDA holds rare second meeting over an ALS drug; U.S. to expand distribution for monkeypox vaccine

Pharma donations to patient charities may violate the ‘spirit’ of anti-kickback laws

Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks

Pharmalittle: Illumina deal for Grail is blocked after EU veto; CVS buys Signify to expand into house calls

Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics

Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics

Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

Up and down the ladder: The latest comings and goings

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day